West Pharmaceutical Services Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$872,300	$844,900	$805,000	$804,300
Gross Profit	329,200	296,400	303,900	293,500
EBITDA	225,300	218,500	209,500	217,100
EBIT	179,100	173,900	162,500	174,100
Net Income	154,000	138,800	132,100	140,000
Net Change In Cash	872,300	844,900	805,000	804,300
Free Cash Flow	80,800	47,200	175,000	133,900
Cash	435,800	521,400	791,300	628,500
Basic Shares	71,300	72,400	72,700	72,700

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,073,700	$2,892,700	$2,951,100	$2,885,500
Gross Profit	1,103,300	1,002,200	1,132,700	1,138,900
EBITDA	770,600	743,800	844,100	808,100
EBIT	599,200	588,400	706,800	687,500
Net Income	493,700	492,700	593,400	585,900
Net Change In Cash	3,073,700	2,892,700	2,951,100	2,885,500
Cost of Revenue				142,200
Free Cash Flow	468,900	276,400	414,500	439,400
Cash	791,300	484,600	853,900	894,300
Basic Shares	72,700	73,700	75,300	75,800